| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
47,486 |
38,912 |
$3.52M |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
29,803 |
26,077 |
$1.54M |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
5,830 |
5,723 |
$426K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
4,946 |
4,863 |
$403K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
12,742 |
12,227 |
$386K |
| 99215 |
Prolong outpt/office vis |
2,967 |
2,705 |
$298K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
3,479 |
3,394 |
$251K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
5,427 |
4,792 |
$223K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
2,576 |
2,478 |
$175K |
| 95165 |
Professional services for the supervision of preparation and provision of antigens for allergen immunotherapy, multiple dose vials |
789 |
113 |
$128K |
| 95004 |
Percutaneous tests with allergenic extracts, immediate type reaction |
497 |
463 |
$109K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
3,556 |
3,374 |
$102K |
| 94760 |
|
45,039 |
36,046 |
$66K |
| 92567 |
|
4,460 |
3,692 |
$57K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
3,603 |
3,451 |
$48K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
3,667 |
2,397 |
$47K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
2,392 |
2,254 |
$47K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
402 |
400 |
$40K |
| 86580 |
|
5,597 |
5,390 |
$38K |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
292 |
289 |
$25K |
| 92551 |
|
4,884 |
4,419 |
$24K |
| 99188 |
|
1,811 |
1,745 |
$20K |
| 99000 |
|
5,987 |
4,947 |
$19K |
| 81002 |
|
5,860 |
5,373 |
$17K |
| 96127 |
|
3,748 |
3,609 |
$16K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
1,205 |
1,185 |
$15K |
| 96160 |
|
6,211 |
5,718 |
$15K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
596 |
507 |
$14K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
935 |
881 |
$13K |
| 94664 |
|
942 |
862 |
$12K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
255 |
242 |
$11K |
| 0071A |
|
136 |
131 |
$10K |
| 93975 |
|
43 |
38 |
$9K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
124 |
122 |
$8K |
| 90461 |
|
673 |
387 |
$8K |
| 99381 |
|
100 |
98 |
$7K |
| 0072A |
|
76 |
72 |
$6K |
| 95117 |
|
630 |
164 |
$5K |
| 99173 |
|
4,177 |
3,736 |
$5K |
| 99382 |
|
40 |
40 |
$3K |
| 82962 |
|
1,069 |
950 |
$3K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
96 |
82 |
$3K |
| 94010 |
|
100 |
91 |
$3K |
| 99383 |
|
32 |
32 |
$3K |
| 0002A |
|
54 |
51 |
$2K |
| 76700 |
Ultrasound, abdominal, real time with image documentation; complete |
23 |
18 |
$1K |
| 0001A |
|
15 |
14 |
$1K |
| 99384 |
|
12 |
12 |
$994.56 |
| 94761 |
|
521 |
458 |
$788.65 |
| A7004 |
Small volume nonfiltered pneumatic nebulizer, disposable |
980 |
862 |
$752.68 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
456 |
392 |
$431.06 |
| 95115 |
|
45 |
14 |
$307.25 |
| 90620 |
|
245 |
201 |
$115.50 |
| 90686 |
|
3,564 |
3,093 |
$96.48 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
269 |
238 |
$54.11 |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
362 |
340 |
$47.38 |
| J7613 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg |
925 |
855 |
$41.92 |
| 91300 |
|
33 |
31 |
$0.07 |
| 90696 |
|
25 |
25 |
$0.00 |
| 90680 |
|
532 |
456 |
$0.00 |
| 90698 |
|
546 |
459 |
$0.00 |
| 90744 |
|
180 |
150 |
$0.00 |
| 90651 |
|
464 |
359 |
$0.00 |
| 90688 |
|
210 |
140 |
$0.00 |
| 90619 |
|
61 |
50 |
$0.00 |
| 90716 |
|
33 |
29 |
$0.00 |
| 90674 |
|
38 |
25 |
$0.00 |
| 90697 |
|
17 |
17 |
$0.00 |
| J3490 |
Unclassified drugs |
16 |
13 |
$0.00 |
| 90707 |
|
29 |
26 |
$0.00 |
| 90633 |
|
311 |
272 |
$0.00 |
| 90734 |
|
539 |
428 |
$0.00 |
| 90670 |
|
1,257 |
1,078 |
$0.00 |
| 90700 |
|
158 |
142 |
$0.00 |
| 90713 |
|
33 |
31 |
$0.00 |
| 90671 |
|
60 |
55 |
$0.00 |
| 90715 |
|
107 |
95 |
$0.00 |
| 90649 |
|
289 |
269 |
$0.00 |
| 90672 |
|
163 |
128 |
$0.00 |
| 90685 |
|
40 |
31 |
$0.00 |
| 90710 |
|
168 |
129 |
$0.00 |
| 90648 |
|
66 |
62 |
$0.00 |